Találati lista | Tudóstér

001-es BibID:	BIBFORM078520
035-os BibID:	(PMID)31002856 (WoS)000466942100010 (Scopus)85064701689
Első szerző:	Keserű Judit (molekuláris genetikus)
Cím:	Detection of cell-free, exosomal and whole blood mitochondrial DNA copy number in plasma or whole blood of patients with serous epithelial ovarian cancer / Keserű J. S., Soltész B., Lukács J., Márton É., Szilágyi-Bónizs M., Penyige A., Póka R., Nagy B.
Dátum:	2019
ISSN:	0168-1656
Megjegyzések:	Ovarian tumor is one of the leading causes of cancer among women. Patients are diagnosed at an advanced stage, usually. There is a need for new specific and sensitive biomarkers. Mitochondrial DNA copy number change was observed in various cancers. Our aim was to detect mitochondrial DNA copy number in whole blood (wb-mtDNA) and in plasma (cell-free and exosome encapsulated mtDNA) in patients with serous epithelial ovarian tumor. DNA was isolated from EDTA blood and plasma obtained from 24 patients and 24 healthy controls. Exosomes were isolated from cell-free plasma, and exosome encapsulated DNA (exoDNA) was extracted. Quantitative-real-time PCR was performed with Human Mitochondrial DNA (mtDNA) Monitoring Primer Set. Kruskall?Wallis and Mann?Whitney U test were used for data analysis. Wb-mtDNA copy number was significantly different among healthy controls and patients in multiple comparison (p?=?0.0090 considering FIGO stage independently, and p?=?0.0048 considering early- and late-stage cancers). There was a significant decrease among early-stage, all advanced stage and all cancer patients (FIGO I: 32.5?±?8.3, p?=?0.0061; FIGO III?+?IV: 37.2?±?13.7 p?=?0.0139; FIGO I?+?III?+?IV: 35.6?±?12.2, p?=?0.0017) or FIGO III patients alone (32.8?±?5.6, p?=?0.00089) compared to healthy controls. We found significant increase in copy number in exosomal mtDNA in cancer patients (236.0?±?499.0, p?=?0.0155), advanced-stage cancer patients (333.0?±?575.0, p?=?0.0095), of FIGO III (362.0?±?609.2, p?=?0.0494), and FIGO IV (304.0?±?585.0, p?=?0.0393) patients alone but not in samples of FIGO I patients (10.0?±?3.5, p?=?0.3907). In multiple comparison the increase was significant considering early- and late-stage cancers (p?=?0.0253). Cell-free mtDNA copy numbers were not increased significantly. We found the highest copy number of mtDNA in exosomes, followed by plasma and peripheral blood in late-stage cancer patients. We observed significant difference in wb-mtDNA copy number between healthy controls and both early- and late-stage cancer patients.
Tárgyszavak:	Orvostudományok Elméleti orvostudományok idegen nyelvű folyóiratközlemény külföldi lapban folyóiratcikk Cell-free mtDNA Exosomal mtDNA Mitochondrial DNA Serous ovarian cancer
Megjelenés:	Journal of Biotechnology. - 298 (2019), p. 76-81. -
További szerzők:	Soltész Beáta (1987-) (molekuláris biológus) Lukács János (1975-) (szülész-nőgyógyász, genetikus) Márton Éva (1992-) (biológus) Szilágyi Melinda (1984-) (biológus) Penyige András (1954-) (molekuláris genetikus) Póka Róbert (1960-) (szülész-nőgyógyász, klinikai onkológus) Nagy Bálint (1956-) (molekuláris genetikus)
Internet cím:	Szerző által megadott URL DOI Intézményi repozitóriumban (DEA) tárolt változat
Borító:
Saját polcon:

001-es BibID:	BIBFORM057736
Első szerző:	Spitzmüller Zsolt (molekuláris biológus)
Cím:	[Gamma]-Glutamyl transpeptidase (GgtA) of Aspergillus nidulans is not necessary for bulk degradation of glutathione / Zsolt Spitzmüller, Nak-Jung Kwon, Melinda Szilágyi, Judit Keserű, Viktória Tóth, Jae-Hyuk Yu, István Pócsi, Tamás Emri
Dátum:	2015
ISSN:	0302-8933 1432-072X
Megjegyzések:	Aspergillus nidulans exhibited high [Gamma]-glutamyl transpeptidase ([Gamma]GT) activity in both carbon-starved and carbon-limited cultures. Glucose repressed, but casein peptone increased [Gamma]GT production. Null mutation of creA did not influence [Gamma]GT formation, but the functional meaBwas necessary for the [Gamma]GT induction. Deletion of the AN10444 gene (ggtA) completely eliminated the [Gamma]GT activity, and the mRNA levels of ggtA showed strong correlation with the observed [Gamma]GT activities. While ggtA does not contain a canonical signal sequence, the [Gamma]GT activity was detectable both in the fermentation broth and in the hyphae. Deletion of the ggtAgene did not prevent the depletion of glutathione observed in carbon-starved and carbon-limited cultures. Addition of casein peptone to carbon-starved cultures lowered the formation of reactive species (RS). Deletion of ggtA could hinder this decrease and resulted in elevated RS formation. This effect of [Gamma]GT on redox homeostasis may explain the reduced cleistothecia formation of ?ggtA strains in surface cultures
Tárgyszavak:	Természettudományok Biológiai tudományok idegen nyelvű folyóiratközlemény külföldi lapban
Megjelenés:	Archives Of Microbiology. - 197 : 2 (2015), p. 285-297. -
További szerzők:	Kwon, Nak-Jung Szilágyi Melinda (1984-) (biológus) Keserű Judit (1976-) (molekuláris genetikus) Tóth Viktória (1984-) (biológus) Yu Jae-Hyuk Pócsi István (1961-) (vegyész) Emri Tamás (1969-) (biológus)
Pályázati támogatás:	TÁMOP-4.2.2.A-11/1/KONV-2012-0045 TÁMOP Gyermekgyógyászat Kutatócsoport
Internet cím:	Szerző által megadott URL DOI Intézményi repozitóriumban (DEA) tárolt változat
Borító:
Saját polcon:

001-es BibID:	bibEBI00026276
035-os BibID:	(cikkazonosító)6827 (scopus)85091140313 (wos)000579918800001
Első szerző:	Szilágyi Melinda (biológus)
Cím:	Circulating cell-free nucleic acids : main characteristics and clinical application / Melinda Szilágyi, Ondrej Pös, Éva Márton, Gergely Buglyó, Beáta Soltész, Judit Keserű, András Penyige, Tomas Szemes, Bálint Nagy
Dátum:	2020
ISSN:	1661-6596 1422-0067
Megjegyzések:	Liquid biopsy recently became a very promising diagnostic method that has several advantages over conventional invasive methods. Liquid biopsy may serve as a source of several important biomarkers including cell-free nucleic acids (cf-NAs). Cf-DNA is widely used in prenatal testing in order to characterize fetal genetic disorders. Analysis of cf-DNA may provide information about the mutation profile of tumor cells, while cell-free non-coding RNAs are promising biomarker candidates in the diagnosis and prognosis of cancer. Many of these markers have the potential to help clinicians in therapy selection and in the follow-up of patients. Thus, cf-NA-based diagnostics represent a new path in personalized medicine. Although several reviews are available in the field, most of them focus on a limited number of cf-NA types. In this review, we give an overview about all known cf-NAs including cf-DNA, cf-mtDNA and cell-free non-coding RNA (miRNA, lncRNA, circRNA, piRNA, YRNA, and vtRNA) by discussing their biogenesis, biological function and potential as biomarker candidates in liquid biopsy. We also outline possible future directions in the field.
Tárgyszavak:	Orvostudományok Elméleti orvostudományok idegen nyelvű folyóiratközlemény külföldi lapban folyóiratcikk cell-free nucleic acids nDNA mtDNA miRNA lncRNA circRNA exosomes biological fluids liquid biopsy
Megjelenés:	International Journal of Molecular Sciences. - 21 : 18 (2020), p. 1-20. -
További szerzők:	Pös, Ondrej (1990-) (biológus) Márton Éva (1992-) (biológus) Buglyó Gergely (1980-) (genetikus) Soltész Beáta (1987-) (molekuláris biológus) Keserű Judit (1976-) (molekuláris genetikus) Penyige András (1954-) (molekuláris genetikus) Szemes, Tomas (1980-) (biológus) Nagy Bálint (1956-) (molekuláris genetikus)
Internet cím:	Szerző által megadott URL DOI Intézményi repozitóriumban (DEA) tárolt változat
Borító:
Saját polcon: